Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5′-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients

Background: The adenosine A2a receptor (A2aR) and the adenosine synthesizing enzyme CD73 have recently evolved as a novel immunotherapeutic target. However, little is known about epigenetic modification of the encoding genes ADORA2A and NT5E. Methods: In the present study, we evaluated methylation a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Timo J. Vogt, Heidrun Gevensleben, Jörn Dietrich, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg, Diane Goltz, Dimo Dietrich
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2018-08-01
Colecção:	OncoImmunology
Assuntos:	adenosine a2a receptor adora2a head and neck squamous cell carcinoma dna methylation biomarker immunotherapy hpv nt5e cd73 prognosis
Acesso em linha:	http://dx.doi.org/10.1080/2162402X.2018.1452579
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!